Get started
Author

H.R. Kim

A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC)
2019 · S. Lee, B.C. Ahn, et al. · Annals of Oncology · 37
The Preoperative Planning, Design, and Execution of the Freestyle Propeller Flap: A Detailed Description and the Case Series
2025 · Hyung Bae Kim, Seong John Han, et al. · Archives of Plastic Surgery · 2
PDF
Corrigendum to “An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterations”
2025 · K.H. Kim, C. Park, et al. · ESMO Open · 1
A phase Ib trial of neoadjuvant chemoradiotherapy and durvalumab (MEDI4736) for potentially resectable stage III non-small cell lung cancer (NSCLC)
2019 · B.C. Ahn, S. Lee, et al. · Annals of Oncology · 1
MA02.10 Different Prognostic Impact of Lymphovascular Invasion Between Lobectomy and Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: A Propensity Score–Matched Analysis
2019 · J.K. Yun, G.D. Lee, et al. · Journal of Thoracic Oncology · 1
PDF
The role of comprehensive evaluation for clinical complete response in predicting pathologic complete response in patients treated with neoadjuvant chemoradiation for esophageal squamous cell carcinoma (ESCC)
2018 · H.-S. Im, J. Kang, et al. · Annals of Oncology · 1
Randomized Phase II Study of Preoperative Concurrent chemoradiotherapy with or without Induction Chemotherapy with S-1 and Oxaliplatin in Patients with Resectable Esophageal Cancer
2012 · D.H. Yoon, G. Jang, et al. · Annals of Oncology · 1
PDF
P2.06.48 Histology-Specific Genomic and Immune Predictors of Resistance to Neoadjuvant Chemoimmunotherapy in Early-Stage Non-Small Cell Lung Cancer
2025 · T.H. Hong, C. Lee, et al. · Journal of Thoracic Oncology
P1.28-11 Recurrence Dynamics for Pathological N2 Non-small Cell Lung Cancer depending on the IASLC Residual Tumor Descriptor
2023 · I.H. Kim, J.K. Yun, et al. · Journal of Thoracic Oncology
PDF
OA11.03 Prognostic Impact of Ground Glass Opacity Component and Consolidation Size after Sublobar Resection: A Quantitative Analysis
2023 · J.Y. Kim, J.K. Yun, et al. · Journal of Thoracic Oncology
PDF
1305P Importance of the resected lung tumor specimen in patients with locally advanced and metastatic non-small cell lung cancer undergoing prior targeted therapy
2023 · J.U. Lim, J.W. Min, et al. · Annals of Oncology
PDF
Supplementary Material for: Close Observation versus Additional Surgery after Noncurative Endoscopic Resection of Esophageal Squamous Cell Carcinoma
2021 · Song, B.G., Kim, G.H., et al. · Figshare
MA01.05 Progress of Accompanying GGN Beyond Pulmonary Resection for Non-Small Cell Lung Cancer
2019 · K. Lee, H.R. Kim, et al. · Journal of Thoracic Oncology
PDF
P1.14-45 Surgical Outcome of Non-Small Cell Lung Cancer with Clinical Single Zone N2 in Aortopulmonary Zone (LN#5 and LN#6)
2019 · K. Lee, H.R. Kim, et al. · Journal of Thoracic Oncology
P1.01-123 Recent Clinical Outcomes of Upfront Surgery Followed by Adjuvant Therapy for Resectable Pathological N2 Non-Small Cell Lung Cancer
2019 · J.K. Yun, Y. Chong, et al. · Journal of Thoracic Oncology
PDF
P2.17-09 Preoperative Risk Factors of Potential Failure for Lobe-Specific Nodal Dissection in Clinical Early Stage (I-IIA) Non-Small Cell Lung Cancer
2019 · Y. Chong, J.K. Yun, et al. · Journal of Thoracic Oncology
Efficacy of palliative chemotherapy (CTx) by lines of treatment in patients (pts) with recurrent/metastatic esophageal squamous cell cancer (SCC): Retrospective analysis of 103 patients in a single center
2018 · E. Kim, S.R. Park, et al. · Annals of Oncology
PDF
PO-403 Discovery of a new potent and mutant-selective EGFR inhibitor that overcomes T790M-mediated resistance in lung cancer
2018 · J.C. Lee, H.R. Kim, et al. · ESMO Open
PO-310 miRNAs in tumor-derived microvesicles promote angiogenesis and tumour cell growth
2018 · J.C. Lee, S.H. Jang, et al. · ESMO Open
P1.16-020 Outcomes of Pulmonary Metastasectomy in Hepatocellular Carcinoma According to Approach Method-Thoracoscopic Versus Open Approach
2017 · H.R. Kim, H.P. Lee, et al. · Journal of Thoracic Oncology
Is Involved Field Radiation Therapy Adequate for Neoadjuvant Concurrent Chemradiation Therapy in Esophageal Cancer?
2017 · S.H. Kim, J.H. Kim, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Prognostic stratification of pathologic stage in patients with preoperative chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma
2017 · J. Kang, S.R. Park, et al. · Annals of Oncology
CDK7 inhibition as a promising therapeutic strategy in lung squamous cell carcinoma with SOX2 amplification
2017 · J.C. Lee, J.Y. Hur, et al. · Annals of Oncology
F-151long-term Outcome of Video-assisted Thoracoscopic Surgery Versus Thoracotomy for Pathological N1 Stage Non-small Cell Lung Cancer
2016 · Su Kyung Hwang, S. Park, et al. · Interactive Cardiovascular and Thoracic Surgery
PDF
078 * Surgical Outcomes After Pulmonary Resection for Non-small-cell Lung Cancer With Unexpected Pleural Metastasis First Detected During Surgery
2014 · J. K. Yun, Y. Kim, et al. · Interactive Cardiovascular and Thoracic Surgery
Works count: 30
Citation count: 81
H-index: 2
I10-index: 2
Year
Topic
Type